Kimia Biosciences touches roof on getting nod to manufacture, market Azelnidipine API

29 Apr 2020 Evaluate

Kimia Biosciences is currently trading at its upper circuit limit of Rs. 24.90, up by 1.15 points or 4.84% from its previous closing of Rs. 23.75 on the BSE.

The scrip opened at Rs. 24.90 and has touched a high and low of Rs. 24.90 and Rs. 22.60 respectively. So far 3718 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 38.00 on 30-Apr-2019 and a 52 week low of Rs. 19.05 on 20-Feb-2020.

Last one week high and low of the scrip stood at Rs. 26.25 and Rs. 22.60 respectively. The current market cap of the company is Rs. 104.76 crore.

The promoters holding in the company stood at 70.93%, while Institutions and Non-Institutions held 0.44% and 28.62% respectively.

Kimia Biosciences has been granted permission to manufacturing and marketing of new active pharmaceutical ingredient Azelnidipine drug by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare.

Kimia Biosciences is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.

Kimia Biosciences Share Price

47.26 0.00 (0.00%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.